Company Performance Metrics
- Eva Steiness: Chief Executive Officer
Serodus ASA is a private Scandinavian drug development company. They focus on developing new treatments with unmet clinical needs in the areas of diabetes and diabetic comorbidities.
Their business model is to in-license drug candidates at an early stage. After having demonstrated clinical effects in humans during clinical phase II, they partner
with international pharmaceutical companies.
Serodus manages the business processes through their extensive network of contract organizations. They are a virtual organization and have no laboratories of their own. The Serodus Management Team combines the weight of Big Pharma experience with the agility of BioPharm decision making and action. The combined experience of their seasoned leadership team spans research, clinical development, business development, and financing. Their individual track records pave the way for long-term success.
All drug candidates are covered by extensive intellectual property (patents and patent applications) held by or licensed to Serodus.
